<DOC>
	<DOCNO>NCT01416363</DOCNO>
	<brief_summary>This study investigate 3 type drug formulation absorb body . This study term 'open-label ' , mean volunteer aware treatment receiving . The study split 2 part . Part 1 , involve volunteer receive 2 new formulation , single dose . There placebo ( dummy-drug ; active ingredient ) study . Volunteers also receive single dose formulation use previous trial ( reference formulation ) , proper comparison new formulation make . The new fomulations administer food reference formulation give without food . In Part 2 , volunteer receive one 3 formulation repeat dose 7 day . Each dos give food .</brief_summary>
	<brief_title>Healthy Volunteer Study Using 3 Different Formulations Firategrast</brief_title>
	<detailed_description>The present study conduct two part healthy male volunteer . Part 1 investigate pharmacokinetics tolerability single dos firategrast administer exist immediate release tablet formulation , modify release tablet ( 3hr ) formulation simulate gastro-retentive formulation administer via naso-gastric tube . Subjects receive formulation randomise 3-way single dose crossover fashion . Part 2 , base review safety , tolerability pharmacokinetic data first two study treatment period Part 1 , investigate pharmacokinetics tolerability multiple dos firategrast administer exist immediate release tablet formulation , modify release tablet ( 3hr ) formulation simulate gastro-retentive formulation administer via naso-gastric tube period 7 day .</detailed_description>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>Male age 18 65 yr inclusive Healthy , determine study physician Capable give iformed consent Positive drug abuse result Positive HIV Hepatitis B and/or C viruses History alcohol consumption excess average recommend weekly intake ( 12 unit male ) Participation clinical trial within 30 day schedule first dose</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>firategrast</keyword>
	<keyword>pharmacokinetics , modify release , firategrast ,</keyword>
	<keyword>simulated gastro-retentive</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>healthy volunteer , simulate gastro-retentive</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>modify release</keyword>
</DOC>